By analyzing the transcriptional profiling of glioma from CCGA (Materials and Methods)22–24, it revealed that higher expression of VEGFA was also associated with poor prognosis for recurrent lower grade astrocytoma (Fig. 4e, log-rank test, P = 0.009). Here, VEGFA is linked to central nervous system cancer.